0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Phacoemulsification Surgical System Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-38C16786
Home | Market Reports | Health| Vision Care
Global Phacoemulsification Surgical System Market Research Report 2024
BUY CHAPTERS

Global Phacoemulsification Surgical System Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-38C16786
Report
November 2025
Pages:172
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Phacoemulsification Surgical System Market

The global Phacoemulsification Surgical System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, General Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Phacoemulsification Surgical System leading manufacturers including Johnson & Johnson, INFINITI, Geuder AG, ALCON, PROTEGE, NIDEC, AMO (Abbott), HOYA, Bausch + Lomb, CARL Zeiss, etc., dominate supply; the top five capture approximately % of global revenue, with Johnson & Johnson leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Phacoemulsification Surgical System market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Phacoemulsification Surgical System Market Report

Report Metric Details
Report Name Phacoemulsification Surgical System Market
Segment by Type
  • Single Pump System
  • Dual-Pump System
Segment by Application
  • General Hospital
  • Eye Clinic
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, INFINITI, Geuder AG, ALCON, PROTEGE, NIDEC, AMO (Abbott), HOYA, Bausch + Lomb, CARL Zeiss, ABBOTT, BVI, OPTIKON, 66 Vision-Tech, Suzhou Kangjie Medical, MEDA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Phacoemulsification Surgical System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Phacoemulsification Surgical System Market report?

Ans: The main players in the Phacoemulsification Surgical System Market are Johnson & Johnson, INFINITI, Geuder AG, ALCON, PROTEGE, NIDEC, AMO (Abbott), HOYA, Bausch + Lomb, CARL Zeiss, ABBOTT, BVI, OPTIKON, 66 Vision-Tech, Suzhou Kangjie Medical, MEDA

What are the Application segmentation covered in the Phacoemulsification Surgical System Market report?

Ans: The Applications covered in the Phacoemulsification Surgical System Market report are General Hospital, Eye Clinic

What are the Type segmentation covered in the Phacoemulsification Surgical System Market report?

Ans: The Types covered in the Phacoemulsification Surgical System Market report are Single Pump System, Dual-Pump System

1 Study Coverage
1.1 Introduction to Phacoemulsification Surgical System: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Phacoemulsification Surgical System Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Single Pump System
1.2.3 Dual-Pump System
1.3 Market Segmentation by Application
1.3.1 Global Phacoemulsification Surgical System Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 General Hospital
1.3.3 Eye Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Phacoemulsification Surgical System Revenue Estimates and Forecasts 2020-2031
2.2 Global Phacoemulsification Surgical System Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Phacoemulsification Surgical System Sales Estimates and Forecasts 2020-2031
2.4 Global Phacoemulsification Surgical System Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Phacoemulsification Surgical System Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Phacoemulsification Surgical System Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Single Pump System Market Size by Manufacturers
3.5.2 Dual-Pump System Market Size by Manufacturers
3.6 Global Phacoemulsification Surgical System Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Phacoemulsification Surgical System Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Phacoemulsification Surgical System Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Phacoemulsification Surgical System Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Phacoemulsification Surgical System Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Phacoemulsification Surgical System Sales and Revenue by Type (2020-2031)
6.4 North America Phacoemulsification Surgical System Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Phacoemulsification Surgical System Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Phacoemulsification Surgical System Sales and Revenue by Type (2020-2031)
7.4 Europe Phacoemulsification Surgical System Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Phacoemulsification Surgical System Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Phacoemulsification Surgical System Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Phacoemulsification Surgical System Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Phacoemulsification Surgical System Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Phacoemulsification Surgical System Sales and Revenue by Type (2020-2031)
9.4 Central and South America Phacoemulsification Surgical System Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Phacoemulsification Surgical System Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Phacoemulsification Surgical System Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Phacoemulsification Surgical System Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Phacoemulsification Surgical System Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Phacoemulsification Surgical System Product Models, Descriptions and Specifications
11.1.4 Johnson & Johnson Phacoemulsification Surgical System Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Johnson & Johnson Phacoemulsification Surgical System Sales by Product in 2024
11.1.6 Johnson & Johnson Phacoemulsification Surgical System Sales by Application in 2024
11.1.7 Johnson & Johnson Phacoemulsification Surgical System Sales by Geographic Area in 2024
11.1.8 Johnson & Johnson Phacoemulsification Surgical System SWOT Analysis
11.1.9 Johnson & Johnson Recent Developments
11.2 INFINITI
11.2.1 INFINITI Corporation Information
11.2.2 INFINITI Business Overview
11.2.3 INFINITI Phacoemulsification Surgical System Product Models, Descriptions and Specifications
11.2.4 INFINITI Phacoemulsification Surgical System Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 INFINITI Phacoemulsification Surgical System Sales by Product in 2024
11.2.6 INFINITI Phacoemulsification Surgical System Sales by Application in 2024
11.2.7 INFINITI Phacoemulsification Surgical System Sales by Geographic Area in 2024
11.2.8 INFINITI Phacoemulsification Surgical System SWOT Analysis
11.2.9 INFINITI Recent Developments
11.3 Geuder AG
11.3.1 Geuder AG Corporation Information
11.3.2 Geuder AG Business Overview
11.3.3 Geuder AG Phacoemulsification Surgical System Product Models, Descriptions and Specifications
11.3.4 Geuder AG Phacoemulsification Surgical System Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Geuder AG Phacoemulsification Surgical System Sales by Product in 2024
11.3.6 Geuder AG Phacoemulsification Surgical System Sales by Application in 2024
11.3.7 Geuder AG Phacoemulsification Surgical System Sales by Geographic Area in 2024
11.3.8 Geuder AG Phacoemulsification Surgical System SWOT Analysis
11.3.9 Geuder AG Recent Developments
11.4 ALCON
11.4.1 ALCON Corporation Information
11.4.2 ALCON Business Overview
11.4.3 ALCON Phacoemulsification Surgical System Product Models, Descriptions and Specifications
11.4.4 ALCON Phacoemulsification Surgical System Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 ALCON Phacoemulsification Surgical System Sales by Product in 2024
11.4.6 ALCON Phacoemulsification Surgical System Sales by Application in 2024
11.4.7 ALCON Phacoemulsification Surgical System Sales by Geographic Area in 2024
11.4.8 ALCON Phacoemulsification Surgical System SWOT Analysis
11.4.9 ALCON Recent Developments
11.5 PROTEGE
11.5.1 PROTEGE Corporation Information
11.5.2 PROTEGE Business Overview
11.5.3 PROTEGE Phacoemulsification Surgical System Product Models, Descriptions and Specifications
11.5.4 PROTEGE Phacoemulsification Surgical System Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 PROTEGE Phacoemulsification Surgical System Sales by Product in 2024
11.5.6 PROTEGE Phacoemulsification Surgical System Sales by Application in 2024
11.5.7 PROTEGE Phacoemulsification Surgical System Sales by Geographic Area in 2024
11.5.8 PROTEGE Phacoemulsification Surgical System SWOT Analysis
11.5.9 PROTEGE Recent Developments
11.6 NIDEC
11.6.1 NIDEC Corporation Information
11.6.2 NIDEC Business Overview
11.6.3 NIDEC Phacoemulsification Surgical System Product Models, Descriptions and Specifications
11.6.4 NIDEC Phacoemulsification Surgical System Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 NIDEC Recent Developments
11.7 AMO (Abbott)
11.7.1 AMO (Abbott) Corporation Information
11.7.2 AMO (Abbott) Business Overview
11.7.3 AMO (Abbott) Phacoemulsification Surgical System Product Models, Descriptions and Specifications
11.7.4 AMO (Abbott) Phacoemulsification Surgical System Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 AMO (Abbott) Recent Developments
11.8 HOYA
11.8.1 HOYA Corporation Information
11.8.2 HOYA Business Overview
11.8.3 HOYA Phacoemulsification Surgical System Product Models, Descriptions and Specifications
11.8.4 HOYA Phacoemulsification Surgical System Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 HOYA Recent Developments
11.9 Bausch + Lomb
11.9.1 Bausch + Lomb Corporation Information
11.9.2 Bausch + Lomb Business Overview
11.9.3 Bausch + Lomb Phacoemulsification Surgical System Product Models, Descriptions and Specifications
11.9.4 Bausch + Lomb Phacoemulsification Surgical System Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Bausch + Lomb Recent Developments
11.10 CARL Zeiss
11.10.1 CARL Zeiss Corporation Information
11.10.2 CARL Zeiss Business Overview
11.10.3 CARL Zeiss Phacoemulsification Surgical System Product Models, Descriptions and Specifications
11.10.4 CARL Zeiss Phacoemulsification Surgical System Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 CARL Zeiss Recent Developments
11.11 ABBOTT
11.11.1 ABBOTT Corporation Information
11.11.2 ABBOTT Business Overview
11.11.3 ABBOTT Phacoemulsification Surgical System Product Models, Descriptions and Specifications
11.11.4 ABBOTT Phacoemulsification Surgical System Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 ABBOTT Recent Developments
11.12 BVI
11.12.1 BVI Corporation Information
11.12.2 BVI Business Overview
11.12.3 BVI Phacoemulsification Surgical System Product Models, Descriptions and Specifications
11.12.4 BVI Phacoemulsification Surgical System Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 BVI Recent Developments
11.13 OPTIKON
11.13.1 OPTIKON Corporation Information
11.13.2 OPTIKON Business Overview
11.13.3 OPTIKON Phacoemulsification Surgical System Product Models, Descriptions and Specifications
11.13.4 OPTIKON Phacoemulsification Surgical System Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 OPTIKON Recent Developments
11.14 66 Vision-Tech
11.14.1 66 Vision-Tech Corporation Information
11.14.2 66 Vision-Tech Business Overview
11.14.3 66 Vision-Tech Phacoemulsification Surgical System Product Models, Descriptions and Specifications
11.14.4 66 Vision-Tech Phacoemulsification Surgical System Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 66 Vision-Tech Recent Developments
11.15 Suzhou Kangjie Medical
11.15.1 Suzhou Kangjie Medical Corporation Information
11.15.2 Suzhou Kangjie Medical Business Overview
11.15.3 Suzhou Kangjie Medical Phacoemulsification Surgical System Product Models, Descriptions and Specifications
11.15.4 Suzhou Kangjie Medical Phacoemulsification Surgical System Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Suzhou Kangjie Medical Recent Developments
11.16 MEDA
11.16.1 MEDA Corporation Information
11.16.2 MEDA Business Overview
11.16.3 MEDA Phacoemulsification Surgical System Product Models, Descriptions and Specifications
11.16.4 MEDA Phacoemulsification Surgical System Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 MEDA Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Phacoemulsification Surgical System Industry Chain
12.2 Phacoemulsification Surgical System Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Phacoemulsification Surgical System Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Phacoemulsification Surgical System Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Phacoemulsification Surgical System Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Phacoemulsification Surgical System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Phacoemulsification Surgical System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Phacoemulsification Surgical System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Phacoemulsification Surgical System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Phacoemulsification Surgical System Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Phacoemulsification Surgical System Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Phacoemulsification Surgical System Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Phacoemulsification Surgical System Sales by Region (2020-2025) & (Units)
 Table 8. Global Phacoemulsification Surgical System Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Phacoemulsification Surgical System Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Phacoemulsification Surgical System Sales Share by Manufacturers (2020-2025)
 Table 12. Global Phacoemulsification Surgical System Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Phacoemulsification Surgical System Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Phacoemulsification Surgical System by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phacoemulsification Surgical System as of 2024)
 Table 16. Global Phacoemulsification Surgical System Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Phacoemulsification Surgical System Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Phacoemulsification Surgical System Manufacturing Base and Headquarters
 Table 19. Global Phacoemulsification Surgical System Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Phacoemulsification Surgical System Sales by Type (2020-2025) & (Units)
 Table 23. Global Phacoemulsification Surgical System Sales by Type (2026-2031) & (Units)
 Table 24. Global Phacoemulsification Surgical System Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Phacoemulsification Surgical System Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Phacoemulsification Surgical System ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Phacoemulsification Surgical System Sales by Application (2020-2025) & (Units)
 Table 29. Global Phacoemulsification Surgical System Sales by Application (2026-2031) & (Units)
 Table 30. Phacoemulsification Surgical System High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Phacoemulsification Surgical System Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Phacoemulsification Surgical System Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Phacoemulsification Surgical System ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Phacoemulsification Surgical System Growth Accelerators and Market Barriers
 Table 37. North America Phacoemulsification Surgical System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Phacoemulsification Surgical System Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Phacoemulsification Surgical System Growth Accelerators and Market Barriers
 Table 40. Europe Phacoemulsification Surgical System Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Phacoemulsification Surgical System Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Phacoemulsification Surgical System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Phacoemulsification Surgical System Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Phacoemulsification Surgical System Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Phacoemulsification Surgical System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Phacoemulsification Surgical System Investment Opportunities and Key Challenges
 Table 47. Central and South America Phacoemulsification Surgical System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Phacoemulsification Surgical System Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Phacoemulsification Surgical System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Johnson & Johnson Corporation Information
 Table 51. Johnson & Johnson Description and Major Businesses
 Table 52. Johnson & Johnson Product Models, Descriptions and Specifications
 Table 53. Johnson & Johnson Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Johnson & Johnson Sales Value Proportion by Product in 2024
 Table 55. Johnson & Johnson Sales Value Proportion by Application in 2024
 Table 56. Johnson & Johnson Sales Value Proportion by Geographic Area in 2024
 Table 57. Johnson & Johnson Phacoemulsification Surgical System SWOT Analysis
 Table 58. Johnson & Johnson Recent Developments
 Table 59. INFINITI Corporation Information
 Table 60. INFINITI Description and Major Businesses
 Table 61. INFINITI Product Models, Descriptions and Specifications
 Table 62. INFINITI Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. INFINITI Sales Value Proportion by Product in 2024
 Table 64. INFINITI Sales Value Proportion by Application in 2024
 Table 65. INFINITI Sales Value Proportion by Geographic Area in 2024
 Table 66. INFINITI Phacoemulsification Surgical System SWOT Analysis
 Table 67. INFINITI Recent Developments
 Table 68. Geuder AG Corporation Information
 Table 69. Geuder AG Description and Major Businesses
 Table 70. Geuder AG Product Models, Descriptions and Specifications
 Table 71. Geuder AG Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Geuder AG Sales Value Proportion by Product in 2024
 Table 73. Geuder AG Sales Value Proportion by Application in 2024
 Table 74. Geuder AG Sales Value Proportion by Geographic Area in 2024
 Table 75. Geuder AG Phacoemulsification Surgical System SWOT Analysis
 Table 76. Geuder AG Recent Developments
 Table 77. ALCON Corporation Information
 Table 78. ALCON Description and Major Businesses
 Table 79. ALCON Product Models, Descriptions and Specifications
 Table 80. ALCON Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. ALCON Sales Value Proportion by Product in 2024
 Table 82. ALCON Sales Value Proportion by Application in 2024
 Table 83. ALCON Sales Value Proportion by Geographic Area in 2024
 Table 84. ALCON Phacoemulsification Surgical System SWOT Analysis
 Table 85. ALCON Recent Developments
 Table 86. PROTEGE Corporation Information
 Table 87. PROTEGE Description and Major Businesses
 Table 88. PROTEGE Product Models, Descriptions and Specifications
 Table 89. PROTEGE Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. PROTEGE Sales Value Proportion by Product in 2024
 Table 91. PROTEGE Sales Value Proportion by Application in 2024
 Table 92. PROTEGE Sales Value Proportion by Geographic Area in 2024
 Table 93. PROTEGE Phacoemulsification Surgical System SWOT Analysis
 Table 94. PROTEGE Recent Developments
 Table 95. NIDEC Corporation Information
 Table 96. NIDEC Description and Major Businesses
 Table 97. NIDEC Product Models, Descriptions and Specifications
 Table 98. NIDEC Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. NIDEC Recent Developments
 Table 100. AMO (Abbott) Corporation Information
 Table 101. AMO (Abbott) Description and Major Businesses
 Table 102. AMO (Abbott) Product Models, Descriptions and Specifications
 Table 103. AMO (Abbott) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. AMO (Abbott) Recent Developments
 Table 105. HOYA Corporation Information
 Table 106. HOYA Description and Major Businesses
 Table 107. HOYA Product Models, Descriptions and Specifications
 Table 108. HOYA Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. HOYA Recent Developments
 Table 110. Bausch + Lomb Corporation Information
 Table 111. Bausch + Lomb Description and Major Businesses
 Table 112. Bausch + Lomb Product Models, Descriptions and Specifications
 Table 113. Bausch + Lomb Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Bausch + Lomb Recent Developments
 Table 115. CARL Zeiss Corporation Information
 Table 116. CARL Zeiss Description and Major Businesses
 Table 117. CARL Zeiss Product Models, Descriptions and Specifications
 Table 118. CARL Zeiss Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. CARL Zeiss Recent Developments
 Table 120. ABBOTT Corporation Information
 Table 121. ABBOTT Description and Major Businesses
 Table 122. ABBOTT Product Models, Descriptions and Specifications
 Table 123. ABBOTT Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. ABBOTT Recent Developments
 Table 125. BVI Corporation Information
 Table 126. BVI Description and Major Businesses
 Table 127. BVI Product Models, Descriptions and Specifications
 Table 128. BVI Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. BVI Recent Developments
 Table 130. OPTIKON Corporation Information
 Table 131. OPTIKON Description and Major Businesses
 Table 132. OPTIKON Product Models, Descriptions and Specifications
 Table 133. OPTIKON Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. OPTIKON Recent Developments
 Table 135. 66 Vision-Tech Corporation Information
 Table 136. 66 Vision-Tech Description and Major Businesses
 Table 137. 66 Vision-Tech Product Models, Descriptions and Specifications
 Table 138. 66 Vision-Tech Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. 66 Vision-Tech Recent Developments
 Table 140. Suzhou Kangjie Medical Corporation Information
 Table 141. Suzhou Kangjie Medical Description and Major Businesses
 Table 142. Suzhou Kangjie Medical Product Models, Descriptions and Specifications
 Table 143. Suzhou Kangjie Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 144. Suzhou Kangjie Medical Recent Developments
 Table 145. MEDA Corporation Information
 Table 146. MEDA Description and Major Businesses
 Table 147. MEDA Product Models, Descriptions and Specifications
 Table 148. MEDA Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 149. MEDA Recent Developments
 Table 150. Key Raw Materials Distribution
 Table 151. Raw Materials Key Suppliers
 Table 152. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 153. Milestones in Production Technology Evolution
 Table 154. Distributors List
 Table 155. Market Trends and Market Evolution
 Table 156. Market Drivers and Opportunities
 Table 157. Market Challenges, Risks, and Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources


List of Figures
 Figure 1. Phacoemulsification Surgical System Product Picture
 Figure 2. Global Phacoemulsification Surgical System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Single Pump System Product Picture
 Figure 4. Dual-Pump System Product Picture
 Figure 5. Global Phacoemulsification Surgical System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. General Hospital
 Figure 7. Eye Clinic
 Figure 8. Phacoemulsification Surgical System Report Years Considered
 Figure 9. Global Phacoemulsification Surgical System Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Phacoemulsification Surgical System Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Phacoemulsification Surgical System Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Phacoemulsification Surgical System Revenue Market Share by Region (2020-2031)
 Figure 13. Global Phacoemulsification Surgical System Sales (2020-2031) & (Units)
 Figure 14. Global Phacoemulsification Surgical System Sales (CAGR) by Region (2020-2031) (Units)
 Figure 15. Global Phacoemulsification Surgical System Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers Phacoemulsification Surgical System Sales Volume Market Share in 2024
 Figure 17. Global Phacoemulsification Surgical System Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Single Pump System Revenue Market Share by Manufacturer in 2024
 Figure 20. Dual-Pump System Revenue Market Share by Manufacturer in 2024
 Figure 21. Global Phacoemulsification Surgical System Sales Market Share by Type (2020-2031)
 Figure 22. Global Phacoemulsification Surgical System Revenue Market Share by Type (2020-2031)
 Figure 23. Global Phacoemulsification Surgical System Sales Market Share by Application (2020-2031)
 Figure 24. Global Phacoemulsification Surgical System Revenue Market Share by Application (2020-2031)
 Figure 25. North America Phacoemulsification Surgical System Sales YoY (2020-2031) & (Units)
 Figure 26. North America Phacoemulsification Surgical System Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers Phacoemulsification Surgical System Sales Revenue (US$ Million) in 2024
 Figure 28. North America Phacoemulsification Surgical System Sales Volume (Units) by Type (2020- 2031)
 Figure 29. North America Phacoemulsification Surgical System Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Phacoemulsification Surgical System Sales Volume (Units) by Application (2020-2031)
 Figure 31. North America Phacoemulsification Surgical System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Phacoemulsification Surgical System Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Phacoemulsification Surgical System Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Phacoemulsification Surgical System Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Phacoemulsification Surgical System Sales YoY (2020-2031) & (Units)
 Figure 36. Europe Phacoemulsification Surgical System Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers Phacoemulsification Surgical System Sales Revenue (US$ Million) in 2024
 Figure 38. Europe Phacoemulsification Surgical System Sales Volume (Units) by Type (2020-2031)
 Figure 39. Europe Phacoemulsification Surgical System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe Phacoemulsification Surgical System Sales Volume (Units) by Application (2020-2031)
 Figure 41. Europe Phacoemulsification Surgical System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany Phacoemulsification Surgical System Revenue (2020-2031) & (US$ Million)
 Figure 43. France Phacoemulsification Surgical System Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. Phacoemulsification Surgical System Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy Phacoemulsification Surgical System Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia Phacoemulsification Surgical System Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific Phacoemulsification Surgical System Sales YoY (2020-2031) & (Units)
 Figure 48. Asia-Pacific Phacoemulsification Surgical System Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers Phacoemulsification Surgical System Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific Phacoemulsification Surgical System Sales Volume (Units) by Type (2020- 2031)
 Figure 51. Asia-Pacific Phacoemulsification Surgical System Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific Phacoemulsification Surgical System Sales Volume (Units) by Application (2020-2031)
 Figure 53. Asia-Pacific Phacoemulsification Surgical System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia Phacoemulsification Surgical System Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan Phacoemulsification Surgical System Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea Phacoemulsification Surgical System Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan Phacoemulsification Surgical System Revenue (2020-2031) & (US$ Million)
 Figure 58. India Phacoemulsification Surgical System Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America Phacoemulsification Surgical System Sales YoY (2020-2031) & (Units)
 Figure 60. Central and South America Phacoemulsification Surgical System Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers Phacoemulsification Surgical System Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America Phacoemulsification Surgical System Sales Volume (Units) by Type (2021-2031)
 Figure 63. Central and South America Phacoemulsification Surgical System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America Phacoemulsification Surgical System Sales Volume (Units) by Application (2020-2031)
 Figure 65. Central and South America Phacoemulsification Surgical System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil Phacoemulsification Surgical System Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina Phacoemulsification Surgical System Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa Phacoemulsification Surgical System Sales YoY (2020-2031) & (Units)
 Figure 69. Middle East and Africa Phacoemulsification Surgical System Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers Phacoemulsification Surgical System Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa Phacoemulsification Surgical System Sales Volume (Units) by Type (2021-2031)
 Figure 72. South America Phacoemulsification Surgical System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa Phacoemulsification Surgical System Sales Volume (Units) by Application (2020-2031)
 Figure 74. Middle East and Africa Phacoemulsification Surgical System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries Phacoemulsification Surgical System Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey Phacoemulsification Surgical System Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt Phacoemulsification Surgical System Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa Phacoemulsification Surgical System Revenue (2020-2025) & (US$ Million)
 Figure 79. Phacoemulsification Surgical System Industry Chain Mapping
 Figure 80. Regional Phacoemulsification Surgical System Manufacturing Base Distribution (%)
 Figure 81. Global Phacoemulsification Surgical System Production Market Share by Region (2020-2031)
 Figure 82. Phacoemulsification Surgical System Production Process
 Figure 83. Regional Phacoemulsification Surgical System Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Single-Port Vitrectomy Cutter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13L12609
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Eye Ultrasound Biomicroscope Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32B20021
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Plano-Convex Laser Lenses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38C19846
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Heated Eye Masks Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2H20253
Thu Nov 27 00:00:00 UTC 2025

Add to Cart